Age-Driven Cardiovascular Risk Scores Differ Across Antiretroviral Regimens Among People Living with HIV in the Colombian Caribbean Region. [PDF]
Parejo Garay SP +6 more
europepmc +1 more source
Pretreatment HIV-1 drug resistance, genetic diversity, and molecular transmission networks among individuals initiating antiretroviral therapy in Luzhou, China. [PDF]
Liu L +9 more
europepmc +1 more source
Association between infant post-natal prophylaxis regimens and pretreatment HIV drug resistance in infected infants. [PDF]
Inzaule SC +14 more
europepmc +1 more source
Drug resistance reversal: an overview of real world success stories. [PDF]
Pennings PS.
europepmc +1 more source
Prevalence and transmission of pretreatment drug resistance and acquired drug resistance among people living with HIV-1 in Chongqing, China, 2014-2024. [PDF]
Gao W, Li J, Li M, He K, Deng R, Yang K.
europepmc +1 more source
Doravirine/islatravir (DOR-ISL) as a new once-daily oral single-tablet regimen for human immunodeficiency virus (HIV) treatment: unmet need or paradox of choice? [PDF]
Achhra AC, Ogbuagu OE.
europepmc +1 more source
Characteristics of patients with HIV/HBV coinfection who were diagnosed with HDV infection. [PDF]
Lembas A +8 more
europepmc +1 more source
Resistance Analysis of Weekly Islatravir Plus Lenacapavir in People With HIV at 48 Weeks. [PDF]
VanderVeen LA +8 more
europepmc +1 more source
Multiclass HIV drug resistance: Case series of treatment-experienced PLHIV with resistance to all antiretroviral classes in Northern Uganda. [PDF]
Kayinda F +4 more
europepmc +1 more source
Early outcomes of South African children with persistent viral non-suppression following switch to dolutegravir-based antiretroviral therapy. [PDF]
Guerrini M +8 more
europepmc +1 more source

